Efficient method for establishing induced pluripotent stem cells

US9506039B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9506039-B2
Application numberUS-201113991341-A
CountryUS
Kind codeB2
Filing dateDec 2, 2011
Priority dateDec 3, 2010
Publication dateNov 29, 2016
Grant dateNov 29, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a method of improving the efficiency of establishment of induced pluripotent stem cells by increasing, in a nuclear reprogramming step of somatic cell, the level of activated form of one or more proteins selected from the group consisting of Ras family members, PI3 kinase, RalGEF, Raf, AKT family members, Rheb, TCL1 and S6K. The invention also provides a method of producing induced pluripotent stem cells by contacting a somatic cell with a nuclear reprogramming substance and one or more of such proteins and nucleic acids that encode such proteins. The invention further provides an induced pluripotent stem cell that has an exogenous nucleic acid encoding such a protein, as well as agents for use in the aforesaid methods.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of producing induced pluripotent stem cells, comprising contacting a somatic cell with a nuclear reprogramming substance(s) and a nucleic acid vector(s) encoding one or more AKT family members, thereby producing functionally pluripotent stem cells, wherein the nuclear reprogramming substance(s) comprises a nucleic acid vector encoding Oct3/4 and optionally comprises a nucleic acid vector(s) encoding one or more substances selected from the gro…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9506039B2 cover?
The invention provides a method of improving the efficiency of establishment of induced pluripotent stem cells by increasing, in a nuclear reprogramming step of somatic cell, the level of activated form of one or more proteins selected from the group consisting of Ras family members, PI3 kinase, RalGEF, Raf, AKT family members, Rheb, TCL1 and S6K. The invention also provides a method of produci…
Who is the assignee on this patent?
Yamanaka Shinya, Takahashi Kazutoshi, Tanabe Koji, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12N5/0696. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).